Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms

Journal of Nutritional Biochemistry

Volumn 14, Issue 7, 2003, Pages 394-400

  Reiber, István ^a   Mezõ, Izabella ^a   Kalina, Ákos ^b   Pálos, Gábor ^b   Romics, László ^b   Császár, Albert ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Apolipoprotein E; DNA polymorphism; Familial combined hyperlipidemia; Lipoprotein lipase; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FAMILIAL HYPERLIPEMIA; FAT INTAKE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; MALE; POSTPRANDIAL STATE; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0042206697     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(03)00061-5     Document Type: Article

References (31)

1. de Bruin T.W., Mailly H.H., van Barlingen R., Fisher M., Castro Cabezas P., Talmud G.M., Dallinga-Thie S.E., Humphries S.E. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest. 26:1996;631-639.
2. Funke H., Klug J., Assmann G. Hind III RFLP in the lipoprotein lipase gene, (LPL). Nuc Acids Res. 15:1987;9102.
3. Regis-Bailly A., Visvikis S., Steinmetz J., Feldmann L., Briancon S., Danchin N., Zannad F., Siest F. Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population. Clin Genet. 50:1996;339-347.
4. Mitchell R.J., Earl L., Bray P., Fripp Y.J., Williams J. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides. Hum Biol. 66:1994;383-397.
5. Chen L., Patsch W., Boerwinkle E. Hindlll DNA polymorphism in the lipoprotein lipase gene and plasma lipid genotypes and carotid artery atherosclerosis. Hum Genet. 98:1996;551-556.
6. Heinzmann C., Ladias J., Antonarakis S., Kirchgessner T., Schotz M., Lusis A.J. RFLP for the human lipoprotein lipase (LPL) gene Hindlll . Nuc Acids Res. 5:1987;6763.
7. Thorn J.A., Chamberlain J.C., Alcolado J.C., Oka K., Chan L., Stocks J., Galton D.J. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis. 85:1990;55-60.
8. Senti M., Bosch M., Aubo C., Elosua R., Masia R., Marrugat J. Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene. Atherosclerosis. 150:2000;135-141.
9. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level a meta- analysis of population-based prospective studies . J Cardiovasc Risk. 3:1996;213-219.
10. Havel R.J. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol. 5:1994;102-109.
11. Zilversmit D.B. Atherogenesis a postprandial phenomenon . Circulation. 60:1979;473-485.
12. Patsch J.R., Miesenbock G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J.K., Gotto A.M., Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12:1992;1336-1345.
13. Schneider W.J., Kovanen P.T., Brown M.S., Goldstein J.L., Utermann G., Weber W., Havel R.J., Kotite L., Kane J.P., Innerarity T.L., Mahley R.W. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest. 68:1981;1075-1085.
14. Steinmetz A., Jakobs C., Motzny S., Kaffarnik H. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis. 9:1989;405-411.
15. Dart A., Sherrard B., Simpson H. Influence of apo E genotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis. 130:1997;161-170.
16. Nikkila M., Solakivi T., Lehtimaki T., Koivula T., Laippala P., Astrom B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E genotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis. 106:1994;149-157.
17. Bredie S.J., Vogelaar J.M., Demacker P.N., Stalenhoef A.F. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia. Atherosclerosis. 126:1996;313-324.
18. Humphries S.E., Nicaud V., Margalef J., Tiret L., Talmud P.J. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides the European Atherosclerosis Research Study (EARS) . Arterioscler Thromb Vasc Biol. 18:1998;526-534.
19. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 6:1988;1215.
20. Peacock R.E., Hamsten A., Nilsson-Ehle P., Humphries S.E. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 97:1992;171-185.
21. Jemaa R., Tuzet S., Portos C., Betoulle D., Apfelbaum M., Fumeron F. Lipoprotein lipase gene polymorphisms associations with hypertriglyceridemia and body mass index in obese people . Int J Obes Relat Metab Disord. 19:1995;270-274.
22. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 31:1990;545-548.
23. Patsch J.R. Postprandial lipaemia. Baillieres Clin Endocrinol Metab. 1:1987;551-580.
24. Pajukanta P., Nuotio I., Terwilliger J.D., Porkka K.V., Ylitalo K., Pihlajamaki J., Suomalainen A.J., Syvanen A.C., Lehtimaki T., Viikari J.S., Laakso M., Taskinen M.R., Ehnholm C., Peltonen L. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet. 18:1998;369-373.
25. Ahn Y.I., Kamboh M.I., Hamman R.F., Cole S.A., Ferrell R.E. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 34:1993;421-428.
26. Gerdes C., Gerdes L.U., Hansen P.S., Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation. 92:1995;1765-1769.
27. Vohl M.C., Lamarche B., Moorjani S., Prud'homme D., Nadeau A., Bouchard C., Lupien P.J., Despres J.P. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol. 15:1995;714-720.
28. Wang X.L., McCredie R.M., Wilcken D.E. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation. 93:1996;1339-1345.
29. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE genotype a meta- analysis . J Lipid Res. 33:1992;447-454.
30. Dallongeville L., Tiret S., Visvikis D.S., O'Reilly M., Saava G., Tsitouris M., Rosseneu G., DeBacker S.E., Humphries S.E., Beisiegel U. Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction the EARS II study . Atherosclerosis. 145:1999;381-388.
31. Groenemeijer M.D., Hallman P.W., Reymer E., Gagne J.A., Groenemeijer B.E., Hallman M.D., Reymer P.W., Gagne E., Kuivenhoven J.A., Bruin T., Jansen H., Lie K.I., Bruschke A.V., Boenwinkle E., Hayden M.R., Kastelein J.J. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene Circulation. 95:1997;2628-2635.